A citation-based method for searching scientific literature

Lena Bohaumilitzky, Magnus von Knebel Doeberitz, Matthias Kloor, Aysel Ahadova. J Clin Med 2020
Times Cited: 7







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
71

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
57

The Immune Biology of Microsatellite-Unstable Cancer.
Matthias Kloor, Magnus von Knebel Doeberitz. Trends Cancer 2016
96
57

Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
Matthias Kloor, Sara Michel, Boris Buckowitz, Josef Rüschoff, Reinhard Büttner, Elke Holinski-Feder, Wolfgang Dippold, Rudolf Wagner, Mirjam Tariverdian, Axel Benner,[...]. Int J Cancer 2007
69
57

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.
Mev Dominguez-Valentin, Julian R Sampson, Toni T Seppälä, Sanne W Ten Broeke, John-Paul Plazzer, Sigve Nakken, Christoph Engel, Stefan Aretz, Mark A Jenkins, Lone Sunde,[...]. Genet Med 2020
130
42

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.
Pål Møller, Toni T Seppälä, Inge Bernstein, Elke Holinski-Feder, Paulo Sala, D Gareth Evans, Annika Lindblom, Finlay Macrae, Ignacio Blanco, Rolf H Sijmons,[...]. Gut 2018
215
42

The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints.
Nicolas J Llosa, Michael Cruise, Ada Tam, Elizabeth C Wicks, Elizabeth M Hechenbleikner, Janis M Taube, Richard L Blosser, Hongni Fan, Hao Wang, Brandon S Luber,[...]. Cancer Discov 2015
779
42

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Michael J Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz-Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill,[...]. J Clin Oncol 2018
751
42

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
Daniel J Sargent, Silvia Marsoni, Genevieve Monges, Stephen N Thibodeau, Roberto Labianca, Stanley R Hamilton, Amy J French, Brian Kabat, Nathan R Foster, Valter Torri,[...]. J Clin Oncol 2010
901
42

Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers.
Adam Shlien, Brittany B Campbell, Richard de Borja, Ludmil B Alexandrov, Daniele Merico, David Wedge, Peter Van Loo, Patrick S Tarpey, Paul Coupland, Sam Behjati,[...]. Nat Genet 2015
203
28

Hereditary factors in cancer. Study of two large midwestern kindreds.
H T Lynch, M W Shaw, C W Magnuson, A L Larsen, A J Krush. Arch Intern Med 1966
292
28

Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
N Lavoine, C Colas, M Muleris, S Bodo, A Duval, N Entz-Werle, F Coulet, O Cabaret, F Andreiuolo, C Charpy,[...]. J Med Genet 2015
68
28

Mismatch repair and DNA damage signalling.
Lovorka Stojic, Richard Brun, Josef Jiricny. DNA Repair (Amst) 2004
291
28

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
Alberto Malesci, Luigi Laghi, Paolo Bianchi, Gabriele Delconte, Ann Randolph, Valter Torri, Carlo Carnaghi, Roberto Doci, Riccardo Rosati, Marco Montorsi,[...]. Clin Cancer Res 2007
174
28

The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria-Luisa Alegre, Jason J Luke, Thomas F Gajewski. Science 2018
957
28

Tumour-intrinsic resistance to immune checkpoint blockade.
Anusha Kalbasi, Antoni Ribas. Nat Rev Immunol 2020
257
28

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
28

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.
Bernhard Mlecnik, Gabriela Bindea, Helen K Angell, Pauline Maby, Mihaela Angelova, David Tougeron, Sarah E Church, Lucie Lafontaine, Maria Fischer, Tessa Fredriksen,[...]. Immunity 2016
532
28

Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome.
Kyle Chang, Melissa W Taggart, Laura Reyes-Uribe, Ester Borras, Erick Riquelme, Reagan M Barnett, Guido Leoni, F Anthony San Lucas, Maria T Catanese, Federica Mori,[...]. JAMA Oncol 2018
35
28

Complex pattern of immune evasion in MSI colorectal cancer.
Mine Ozcan, Jonas Janikovits, Magnus von Knebel Doeberitz, Matthias Kloor. Oncoimmunology 2018
58
28

The consensus molecular subtypes of colorectal cancer.
Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laetitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino,[...]. Nat Med 2015
28

Hereditary colorectal cancer.
Henry T Lynch, Albert de la Chapelle. N Engl J Med 2003
28

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
Jesse M Zaretsky, Angel Garcia-Diaz, Daniel S Shin, Helena Escuin-Ordinas, Willy Hugo, Siwen Hu-Lieskovan, Davis Y Torrejon, Gabriel Abril-Rodriguez, Salemiz Sandoval, Lucas Barthly,[...]. N Engl J Med 2016
28

Microsatellite instability in colorectal cancer.
C Richard Boland, Ajay Goel. Gastroenterology 2010
28

Chemotherapeutic implications in microsatellite unstable colorectal cancer.
Won-Seok Jo, John M Carethers. Cancer Biomark 2006
49
28

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.
Dung T Le, Tae Won Kim, Eric Van Cutsem, Ravit Geva, Dirk Jäger, Hiroki Hara, Matthew Burge, Bert O'Neil, Petr Kavan, Takayuki Yoshino,[...]. J Clin Oncol 2020
211
28

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.
Eric Bouffet, Valérie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy,[...]. J Clin Oncol 2016
453
28



Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer.
Carino Gurjao, David Liu, Matan Hofree, Saud H AlDubayan, Isaac Wakiro, Mei-Ju Su, Kristen Felt, Evisa Gjini, Lauren K Brais, Asaf Rotem,[...]. Cancer Immunol Res 2019
27
28

Milestones of Lynch syndrome: 1895-2015.
Henry T Lynch, Carrie L Snyder, Trudy G Shaw, Christopher D Heinen, Megan P Hitchins. Nat Rev Cancer 2015
345
28

Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
A Tikidzhieva, A Benner, S Michel, A Formentini, K-H Link, W Dippold, M von Knebel Doeberitz, M Kornmann, M Kloor. Br J Cancer 2012
50
28

The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution.
Alexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, Saskia Haupt, Elisabeth Pfaffendorf, Florian Seidler, Johannes Witt, Alejandro Hernandez Sanchez, Katharina Urban, Markus Draxlbauer,[...]. Nat Commun 2020
22
28

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Yvette Schwitalle, Matthias Kloor, Susanne Eiermann, Michael Linnebacher, Peter Kienle, Hanns Peter Knaebel, Mirjam Tariverdian, Axel Benner, Magnus von Knebel Doeberitz. Gastroenterology 2008
228
28

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer.
Pamela Salman, Sergio Panay, René Fernández, Mauricio Mahave, Cristian Soza-Ried. Onco Targets Ther 2018
4
50

High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer.
Jonas Janikovits, Meike Müller, Julia Krzykalla, Sandrina Körner, Fabian Echterdiek, Bernd Lahrmann, Niels Grabe, Martin Schneider, Axel Benner, Magnus von Knebel Doeberitz,[...]. Oncoimmunology 2017
29
28

Identification of Lynch syndrome among patients with colorectal cancer.
Leticia Moreira, Francesc Balaguer, Noralane Lindor, Albert de la Chapelle, Heather Hampel, Lauri A Aaltonen, John L Hopper, Loic Le Marchand, Steven Gallinger, Polly A Newcomb,[...]. JAMA 2012
303
28

Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.
Chen Yang, Frances Austin, Hope Richard, Michael Idowu, Vernell Williamson, Fernanda Sabato, Andrea Ferreira-Gonzalez, Scott A Turner. Cold Spring Harb Mol Case Stud 2019
9
28

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
Robert D Schreiber, Lloyd J Old, Mark J Smyth. Science 2011
28

Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.
Paul Barrow, Susan D Richman, Andrew J Wallace, Kelly Handley, Gordon G A Hutchins, David Kerr, Laura Magill, D Gareth Evans, Richard Gray, Phil Quirke,[...]. Histopathology 2019
8
28

PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells.
Rajeev Kumar, Fang Yu, Yuan-Huan Zhen, Bo Li, Jun Wang, Yuan Yang, Hui-Xin Ge, Ping-Sheng Hu, Jin Xiu. Onco Targets Ther 2017
14
14

Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures.
Iradj Sobhani, Emma Bergsten, Séverine Couffin, Aurélien Amiot, Biba Nebbad, Caroline Barau, Nicola de'Angelis, Sylvie Rabot, Florence Canoui-Poitrine, Denis Mestivier,[...]. Proc Natl Acad Sci U S A 2019
54
14

Normalization of the microbiota in patients after treatment for colonic lesions.
Marc A Sze, Nielson T Baxter, Mack T Ruffin, Mary A M Rogers, Patrick D Schloss. Microbiome 2017
28
14

Can oral bacteria affect the microbiome of the gut?
Ingar Olsen, Kazuhisa Yamazaki. J Oral Microbiol 2019
79
14

Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer.
Xinqiang Wu, Yuanbing Wu, Liangmei He, Longhuo Wu, Xiangcai Wang, Zhiping Liu. J Cancer 2018
65
14

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.
Fay Kastrinos, Hajime Uno, Chinedu Ukaegbu, Carmelita Alvero, Ashley McFarland, Matthew B Yurgelun, Matthew H Kulke, Deborah Schrag, Jeffrey A Meyerhardt, Charles S Fuchs,[...]. J Clin Oncol 2017
71
14

The Gut Microbiota in Immune-Mediated Inflammatory Diseases.
Jessica D Forbes, Gary Van Domselaar, Charles N Bernstein. Front Microbiol 2016
186
14

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
Matthias Kloor, Cathrin Huth, Anita Y Voigt, Axel Benner, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker. Lancet Oncol 2012
85
14

Gut microbiome development along the colorectal adenoma-carcinoma sequence.
Qiang Feng, Suisha Liang, Huijue Jia, Andreas Stadlmayr, Longqing Tang, Zhou Lan, Dongya Zhang, Huihua Xia, Xiaoying Xu, Zhuye Jie,[...]. Nat Commun 2015
484
14

Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer.
Kaitlin J Flynn, Nielson T Baxter, Patrick D Schloss. mSphere 2016
76
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.